Allurion Technologies (ALUR) Common Equity (2022 - 2026)
Allurion Technologies (ALUR) posted Common Equity of -$77.9 million for Q1 2026, down 0.93% on a QoQ basis from -$77.2 million in Q4 2025, and down 11.63% year-over-year from -$88.2 million in Q1 2025.
Allurion Technologies (ALUR) Common Equity (2022 - 2026) Analysis & Trends
Allurion Technologies' Common Equity history runs 5 years deep, the most recent figure standing at -$77.9 million for Q1 2026.
- Quarterly Common Equity fell 11.63% year-over-year to -$77.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$77.9 million (down 11.63% YoY) and the FY2025 annual result came in at -$77.2 million, up 1.01% from the prior year.
- Common Equity was -$77.9 million for Q1 2026 at Allurion Technologies, down from -$77.2 million in the prior quarter.
- Across five years, Common Equity topped out at -$6.7 million in Q2 2022 and bottomed at -$82.9 million in Q3 2025.
- A 5-year average of -$59.7 million and a median of -$68.0 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity sank 962.0% — and 2025, when it advanced 9.36%.
- Allurion Technologies' Common Equity stood at -$32.3 million in 2022, then sank by 120.64% to -$71.3 million in 2023, then fell by 9.37% to -$78.0 million in 2024, then climbed by 1.01% to -$77.2 million in 2025, then slipped by 0.93% to -$77.9 million in 2026.
- Business Quant data shows ALUR's Common Equity at -$77.9 million in Q1 2026, -$77.2 million in Q4 2025, and -$82.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -77.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.91 Mn |
| Dec 31, 2025 | -77.19 Mn |
| Sep 30, 2025 | -82.93 Mn |
| Jun 30, 2025 | -63.98 Mn |
| Mar 31, 2025 | -69.79 Mn |
| Dec 31, 2024 | -77.98 Mn |
| Sep 30, 2024 | -64.79 Mn |
| Jun 30, 2024 | -70.58 Mn |
| Mar 31, 2024 | -66.16 Mn |
| Dec 31, 2023 | -71.30 Mn |
| Sep 30, 2023 | -52.76 Mn |
| Jun 30, 2023 | -71.22 Mn |
| Mar 31, 2023 | -49.66 Mn |
| Dec 31, 2022 | -32.31 Mn |
| Sep 30, 2022 | -20.17 Mn |
| Jun 30, 2022 | -6.71 Mn |